Key facts
- This page summarizes Matthew Angel's Form 3 filing for Tempest Therapeutics, Inc. (TPST).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Feb 2026, 16:24.
Matthew Angel - 03 Feb 2026 Form 3 Insider Report for Tempest Therapeutics, Inc. (TPST)
- Reporting relationship
- CEO and President, Director, 10%+ Owner
- Issuer ticker
- TPST
- Reported as of
- 03 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 06 Feb 2026, 16:24:53 UTC
- Prior SEC filing
- 13 Jan 2023
- Next SEC filing
- 06 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Angel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew Angel filed Form 3 for Tempest Therapeutics, Inc. (TPST) on 06 Feb 2026.
Change
- Previous filing in this sequence was filed on 13 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001931356
Primary reporting owner
Angel Matthew
- Relationship
- CEO and President, Director, 10%+ Owner
- Address
- C/O TEMPEST THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE
- Signature
- /s/ Matthew Angel
- Signature date
- 06 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TPST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,268,495
- Date
- 03 Feb 2026
- Ownership
- By Erigen LLC
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares are held by Erigen LLC (the "LLC"). The Reporting Person is a member of the LLC and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.